Jane Street
RMD icon

Jane Street’s ResMed RMD Stock Holding History

Jane Street’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.5M Buy
43,600
+26,500
+155% +$5.49M ﹤0.01% 3027
2026
Q1 		$3.84M Sell
17,100
-44,300
-72% -$11M ﹤0.01% 3932
2025
Q4 		$14.8M Buy
61,400
+9,200
+18% +$2.35M ﹤0.01% 1881
2025
Q3 		$14.3M Buy
52,200
+34,200
+190% +$9.34M ﹤0.01% 1991
2025
Q2 		$4.64M Sell
18,000
-24,400
-58% -$5.82M ﹤0.01% 3106
2025
Q1 		$9.49M Buy
42,400
+23,300
+122% +$5.44M ﹤0.01% 2057
2024
Q4 		$4.37M Sell
19,100
-29,500
-61% -$7.1M ﹤0.01% 2856
2024
Q3 		$11.9M Buy
48,600
+8,700
+22% +$1.94M ﹤0.01% 1733
2024
Q2 		$7.64M Buy
39,900
+2,300
+6% +$467K ﹤0.01% 2358
2024
Q1 		$7.45M Sell
37,600
-10,700
-22% -$1.96M ﹤0.01% 2116
2023
Q4 		$8.31M Buy
48,300
+600
+1% +$92.2K ﹤0.01% 2180
2023
Q3 		$7.05M Buy
47,700
+44,500
+1,391% +$8.05M ﹤0.01% 2177
2023
Q2 		$699K Buy
3,200
+900
+39% +$201K ﹤0.01% 5792
2023
Q1 		$504K Sell
2,300
-2,400
-51% -$521K ﹤0.01% 6306
2022
Q4 		$978K Sell
4,700
-20,300
-81% -$4.46M ﹤0.01% 5018
2022
Q3 		$5.46M Sell
25,000
-42,400
-63% -$9.65M ﹤0.01% 2471
2022
Q2 		$14.1M Buy
67,400
+13,600
+25% +$2.9M 0.01% 1408
2022
Q1 		$13M Buy
53,800
+39,200
+268% +$9.48M ﹤0.01% 1663
2021
Q4 		$3.8M Sell
14,600
-43,100
-75% -$11.2M ﹤0.01% 3288
2021
Q3 		$15.2M Buy
57,700
+11,300
+24% +$3.09M 0.01% 1340
2021
Q2 		$11.4M Buy
46,400
+37,900
+446% +$7.97M ﹤0.01% 1567
2021
Q1 		$1.65M Sell
8,500
-3,100
-27% -$622K ﹤0.01% 4403
2020
Q4 		$2.47M Sell
11,600
-55,100
-83% -$11M ﹤0.01% 3144
2020
Q3 		$11.4M Buy
66,700
+26,300
+65% +$4.86M 0.01% 1118
2020
Q2 		$7.76M Buy
40,400
+23,700
+142% +$3.88M 0.01% 1382
2020
Q1 		$2.46M Buy
+16,700
New +$2.66M ﹤0.01% 1810
2019
Q1 		– Sell
-7,000
Closed -$797K – 5527
2018
Q4 		$797K Buy
+7,000
New +$750K ﹤0.01% 2882

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jane Street's RMD Position: Q2 2026 in Review

Jane Street reduced its ResMed (RMD) stake by 18% in Q2 2026, selling an estimated $286K and leaving 6,211 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #6135.

Jane Street first reported a position in RMD in Q2 2013 and has held it in 43 quarters since. The position peaked at $91.2M in Q4 2023. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Jane Street held 6,211 shares of ResMed worth $1.21M as of Q2 2026.
  • Jane Street sold 1,378 ResMed shares in Q2 2026, an estimated $286K.
  • ResMed made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #6135 holding.
  • Jane Street first reported a position in ResMed in Q2 2013 and has held it in 43 quarters since.
  • Jane Street's ResMed position peaked at $91.2M in Q4 2023.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.